Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 312

    1.

    Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina.

    Podlekareva DN, Mocroft A, Post FA, Riekstina V, Miro JM, Furrer H, Bruyand M, Panteleev AM, Rakhmanova AG, Girardi E, Losso MH, Toibaro JJ, Caylá J, Miller RF, Obel N, Skrahina A, Chentsova N, Lundgren JD, Kirk O; HIV/TB Study Writing Group.

    AIDS. 2009 Nov 27;23(18):2485-95.PMID: 19898216 [PubMed - in process]Related articles

    2.

    Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir.

    Kowalska J, Kirk O, Mocroft A, Høj L, Friis-Møller N, Reiss P, Weller I, Lundgren J.

    HIV Med. 2009 Oct 27. [Epub ahead of print]PMID: 19863618 [PubMed - as supplied by publisher]Related articles

    3.

    A biobehavioural model of the night eating syndrome.

    Stunkard AJ, Allison KC, Lundgren JD, O'Reardon JP.

    Obes Rev. 2009 Nov;10 Suppl 2:69-77.PMID: 19849804 [PubMed - in process]Related articles

    4.

    Interleukin-2 therapy in patients with HIV infection.

    INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee, Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D.

    N Engl J Med. 2009 Oct 15;361(16):1548-59.PMID: 19828532 [PubMed - indexed for MEDLINE]Related articles

    5.

    Development of criteria for a diagnosis: lessons from the night eating syndrome.

    Stunkard AJ, Allison KC, Geliebter A, Lundgren JD, Gluck ME, O'Reardon JP.

    Compr Psychiatry. 2009 Sep-Oct;50(5):391-9. Epub 2008 Nov 26. Review.PMID: 19683608 [PubMed - indexed for MEDLINE]Related articles

    6.

    Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.

    Rodger AJ, Fox Z, Lundgren JD, Kuller LH, Boesecke C, Gey D, Skoutelis A, Goetz MB, Phillips AN; INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group.

    J Infect Dis. 2009 Sep 15;200(6):973-83.PMID: 19678756 [PubMed - indexed for MEDLINE]Related articles

    7.

    Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.

    Cozzi-Lepri A, Phillips AN, Martinez-Picado J, Monforte A, Katlama C, Eg Hansen AB, Horban A, Bruun J, Clotet B, Lundgren JD; EuroSIDA Study Group.

    J Infect Dis. 2009 Sep 1;200(5):687-97.PMID: 19604043 [PubMed - indexed for MEDLINE]Related articles

    8.

    Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.

    Kesselring AM, Wit FW, Sabin CA, Lundgren JD, Gill MJ, Gatell JM, Rauch A, Montaner JS, de Wolf F, Reiss P, Mocroft A; Nevirapine Toxicity Multicohort Collaboration.

    AIDS. 2009 Aug 24;23(13):1689-99.PMID: 19487907 [PubMed - in process]Related articles

    9.

    Cost-effectiveness of strategies for monitoring the response to antiretroviral therapy in resource-limited settings.

    Phillips AN, Gilks C, Lundgren JD.

    Arch Intern Med. 2009 May 11;169(9):904; author reply 904-5. No abstract available. PMID: 19433706 [PubMed - indexed for MEDLINE]Related articles

    10.

    Proposed diagnostic criteria for night eating syndrome.

    Allison KC, Lundgren JD, O'Reardon JP, Geliebter A, Gluck ME, Vinai P, Mitchell JE, Schenck CH, Howell MJ, Crow SJ, Engel S, Latzer Y, Tzischinsky O, Mahowald MW, Stunkard AJ.

    Int J Eat Disord. 2009 Apr 17. [Epub ahead of print]PMID: 19378289 [PubMed - as supplied by publisher]Related articles

    11.

    Guidelines for managing cardiovascular risk: an evolving area.

    Currier JS, Lundgren JD.

    Curr Opin HIV AIDS. 2008 May;3(3):205-6.PMID: 19372967 [PubMed - in process]Related articles

    12.

    Differences in serotonin transporter binding affinity in patients with major depressive disorder and night eating syndrome.

    Lundgren JD, Amsterdam J, Newberg A, Allison KC, Wintering N, Stunkard AJ.

    Eat Weight Disord. 2009 Mar;14(1):45-50.PMID: 19367140 [PubMed - indexed for MEDLINE]Related articles

    13.

    Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression.

    Peters L, Mocroft A, Soriano V, Rockstroh JK, Losso M, Valerio L, Aldins P, Reiss P, Ledergerber B, Lundgren JD; EuroSIDA Study Group.

    J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):457-63.PMID: 19360931 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Risk of virus transmission from well-treated patients with HIV?]

    Gerstoft J, Mathiesen L, Lundgren JD, Nielsen HI, Pedersen C, Obel N, Laursen A.

    Ugeskr Laeger. 2009 Mar 23;171(13):1085. Danish. No abstract available. PMID: 19321080 [PubMed - indexed for MEDLINE]Related articles

    15.

    Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study.

    van Luin M, Bannister WP, Mocroft A, Reiss P, Di Perri G, Peytavin G, Molto J, Karlson A, Castagna A, Beniowski M, Lundgren JD, Burger DM; EuroSIDA Study Group.

    Antivir Ther. 2009;14(1):75-83.PMID: 19320239 [PubMed - indexed for MEDLINE]Related articles

    16.

    Uncertainty as to whether the use of antiretroviral therapy for persons recently infected with HIV has a favorable risk-to-benefit ratio.

    Lundgren JD, Phillips AN, Neaton J.

    Clin Infect Dis. 2009 Apr 15;48(8):1162; author reply 1162-3. No abstract available. PMID: 19292638 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Major breakthroughs in the medical treatment]

    Kirk O, Gerstoft J, Lundgren JD, Obel N.

    Ugeskr Laeger. 2009 Mar 2;171(10):787-9. Danish. PMID: 19265601 [PubMed - indexed for MEDLINE]Related articles

    18.

    Use of risk equations for predicting disease progression in HIV infection.

    Mocroft A, Lundgren JD.

    Clin Infect Dis. 2009 Apr 1;48(7):951-3. No abstract available. PMID: 19226232 [PubMed - indexed for MEDLINE]Related articles

    19.

    Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

    Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, El-Sadr W, Monforte AD, Kirk O, Fontas E, Dabis F, Law MG, Lundgren JD, Friis-Møller N.

    Circulation. 2009 Feb 17;119(6):805-11. Epub 2009 Feb 2.PMID: 19188509 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Night eating patterns of patients with bulimia nervosa: a preliminary report.

    Lundgren JD, Shapiro JR, Bulik CM.

    Eat Weight Disord. 2008 Dec;13(4):171-5.PMID: 19169072 [PubMed - indexed for MEDLINE]Related articles

    21.

    Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.

    Worm SW, Sabin CA, Reiss P, El-Sadr W, Monforte A, Pradier C, Thiebaut R, Law M, Rickenbach M, De Wit S, Lundgren JD, Friis-Møller N.

    Diabetes Care. 2009 Mar;32(3):474-80. Epub 2008 Dec 3.PMID: 19056612 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Interruption of antiretroviral therapy is associated with increased plasma cystatin C.

    Mocroft A, Wyatt C, Szczech L, Neuhaus J, El-Sadr W, Tracy R, Kuller L, Shlipak M, Angus B, Klinker H, Ross M; INSIGHT SMART Study Group.

    AIDS. 2009 Jan 2;23(1):71-82.PMID: 19050388 [PubMed - indexed for MEDLINE]Related articles

    23.

    Remission of metabolic syndrome following a 15-week low-calorie lifestyle change program for weight loss.

    Lundgren JD, Malcolm R, Binks M, O'Neil PM.

    Int J Obes (Lond). 2009 Jan;33(1):144-50. Epub 2008 Nov 18.PMID: 19015662 [PubMed - indexed for MEDLINE]Related articles

    24.

    The role of HIV in serious diseases other than AIDS.

    Phillips AN, Neaton J, Lundgren JD.

    AIDS. 2008 Nov 30;22(18):2409-18. Review. No abstract available. PMID: 19005264 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?

    Reekie J, Mocroft A, Sambatakou H, Machala L, Chiesi A, van Lunzen J, Clumeck N, Kirk O, Gazzard B, Lundgren JD; EuroSIDA Study Group.

    AIDS. 2008 Nov 12;22(17):2381-90.PMID: 18981778 [PubMed - indexed for MEDLINE]Related articles

    26.

    Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.

    Fox Z, Phillips A, Cohen C, Neuhaus J, Baxter J, Emery S, Hirschel B, Hullsiek KH, Stephan C, Lundgren J; SMART Study Group.

    AIDS. 2008 Nov 12;22(17):2279-89.PMID: 18981767 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study.

    Tedaldi E, Peters L, Neuhaus J, Puoti M, Rockstroh J, Klein MB, Dore GJ, Mocroft A, Soriano V, Clotet B, Lundgren JD; SMART Study Group and International Network for Strategic Initiatives in Global HIV Trials (INSIGHT).

    Clin Infect Dis. 2008 Dec 1;47(11):1468-75.PMID: 18959492 [PubMed - indexed for MEDLINE]Related articles

    28.

    The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results.

    Podlekareva D, Bannister W, Mocroft A, Abrosimova L, Karpov I, Lundgren JD, Kirk O; EuroSIDA Study Group.

    Cent Eur J Public Health. 2008 Sep;16(3):99-105. Review.PMID: 18935770 [PubMed - indexed for MEDLINE]Related articles

    29.

    Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.

    Cozzi-Lepri A, Phillips AN, Clotet B, Mocroft A, Ruiz L, Kirk O, Lazzarin A, Wiercinska-Drapalo A, Karlsson A, Lundgren JD; EuroSIDA Study Group.

    AIDS. 2008 Oct 18;22(16):2187-98.PMID: 18832882 [PubMed - indexed for MEDLINE]Related articles

    30.

    HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.

    Monforte A, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, Kirk O, Law M, De Wit S, Friis-Møller N, Phillips AN, Sabin CA, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.

    AIDS. 2008 Oct 18;22(16):2143-53.PMID: 18832878 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    The elusive search for an HIV vaccine--and what to do meanwhile.

    Lazarus JV, Häggblom A, Kirkegaard L, Lundgren JD, Matic S.

    Vaccine. 2008 Dec 2;26(51):6491-3. No abstract available. PMID: 18817836 [PubMed - indexed for MEDLINE]Related articles

    32.

    Incidence of abacavir hypersensitivity reactions in euroSIDA.

    Bannister WP, Friis-Møller N, Mocroft A, Viard JP, van Lunzen J, Kirk O, Gargalianos P, Bánhegyi D, Chiesi A, Lundgren JD; EuroSIDA Study Group.

    Antivir Ther. 2008;13(5):687-96.PMID: 18771052 [PubMed - indexed for MEDLINE]Related articles

    33.

    Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.

    SMART Study Group, El-Sadr WM, Grund B, Neuhaus J, Babiker A, Cohen CJ, Darbyshire J, Emery S, Lundgren JD, Phillips A, Neaton JD.

    Ann Intern Med. 2008 Sep 2;149(5):289-99.PMID: 18765698 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients.

    Strategies for Management of Anti-Retroviral Therapy/INSIGHT; DAD Study Groups.

    AIDS. 2008 Sep 12;22(14):F17-24.PMID: 18753925 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Prediction of phenotypic susceptibility to antiretroviral drugs using physiochemical properties of the primary enzymatic structure combined with artificial neural networks.

    Kjaer J, Høj L, Fox Z, Lundgren JD.

    HIV Med. 2008 Oct;9(8):642-52. Epub 2008 Jul 8.PMID: 18631257 [PubMed - indexed for MEDLINE]Related articles

    36.

    The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients.

    Jensen JU, Lundgren B, Hein L, Mohr T, Petersen PL, Andersen LH, Lauritsen AO, Hougaard S, Mantoni T, Bømler B, Thornberg KJ, Thormar K, Løken J, Steensen M, Carl P, Petersen JA, Tousi H, Søe-Jensen P, Bestle M, Hestad S, Andersen MH, Fjeldborg P, Larsen KM, Rossau C, Thomsen CB, Ostergaard C, Kjaer J, Grarup J, Lundgren JD.

    BMC Infect Dis. 2008 Jul 13;8:91.PMID: 18620598 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption.

    Gordin FM, Roediger MP, Girard PM, Lundgren JD, Miro JM, Palfreeman A, Rodriguez-Barradas MC, Wolff MJ, Easterbrook PJ, Clezy K, Slater LN.

    Am J Respir Crit Care Med. 2008 Sep 15;178(6):630-6. Epub 2008 Jul 10.PMID: 18617640 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cART.

    Podlekareva D, Mocroft A, Kirk O, Reiss P, Aldins P, Katlama C, Kovari H, Stellbrink HJ, D'Arminio Monforte A, Lundgren JD; Eurosida Study Group.

    Scand J Infect Dis. 2008;40(11-12):908-13.PMID: 18609197 [PubMed - indexed for MEDLINE]Related articles

    39.

    Indicator disease-guided testing for HIV--the next step for Europe?

    Gazzard B, Clumeck N, d'Arminio Monforte A, Lundgren JD.

    HIV Med. 2008 Jul;9 Suppl 2:34-40. Review.PMID: 18557871 [PubMed - indexed for MEDLINE]Related articles

    40.

    Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response.

    Deforche K, Cozzi-Lepri A, Theys K, Clotet B, Camacho RJ, Kjaer J, Van Laethem K, Phillips A, Moreau Y, Lundgren JD, Vandamme AM; EuroSIDA Study Group.

    Antivir Ther. 2008;13(3):399-407.PMID: 18572753 [PubMed - indexed for MEDLINE]Related articles

    41.

    State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary.

    Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dubé MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PW, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH.

    Circulation. 2008 Jul 8;118(2):198-210. Epub 2008 Jun 19. No abstract available. Erratum in: Circulation. 2008 Aug 5;118(6):e109. PMID: 18566320 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy.

    Currier JS, Lundgren JD, Carr A, Klein D, Sabin CA, Sax PE, Schouten JT, Smieja M; Working Group 2.

    Circulation. 2008 Jul 8;118(2):e29-35. Epub 2008 Jun 19. No abstract available. Erratum in: Circulation. 2008 Aug 5;118(6):e108. PMID: 18566319 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    A descriptive study of non-obese persons with night eating syndrome and a weight-matched comparison group.

    Lundgren JD, Allison KC, O'Reardon JP, Stunkard AJ.

    Eat Behav. 2008 Aug;9(3):343-51. Epub 2008 Jan 12.PMID: 18549994 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.

    Bannister WP, Cozzi-Lepri A, Clotet B, Mocroft A, Kjaer J, Reiss P, von Wyl V, Lazzarin A, Katlama C, Phillips AN, Ruiz L, Lundgren JD; EuroSIDA study group.

    J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):324-33.PMID: 18545152 [PubMed - indexed for MEDLINE]Related articles

    45.

    Modeling circadian rhythms of food intake by means of parametric deconvolution: results from studies of the night eating syndrome.

    Boston RC, Moate PJ, Allison KC, Lundgren JD, Stunkard AJ.

    Am J Clin Nutr. 2008 Jun;87(6):1672-7.PMID: 18541555 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.

    Phillips AN, Carr A, Neuhaus J, Visnegarwala F, Prineas R, Burman WJ, Williams I, Drummond F, Duprez D, Belloso WH, Goebel FD, Grund B, Hatzakis A, Vera J, Lundgren JD.

    Antivir Ther. 2008;13(2):177-87.PMID: 18505169 [PubMed - indexed for MEDLINE]Related articles

    47.

    Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.

    Strategies for Management of Antiretroviral Therapy (SMART) Study Group, Lundgren JD, Babiker A, El-Sadr W, Emery S, Grund B, Neaton JD, Neuhaus J, Phillips AN.

    J Infect Dis. 2008 Apr 15;197(8):1145-55.PMID: 18476293 [PubMed - indexed for MEDLINE]Related articles

    48.

    Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.

    Strategies for Management of Antiretroviral Therapy (SMART) Study Group, Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, Girard PM, Grund B, Law M, Losso MH, Palfreeman A, Wood R.

    J Infect Dis. 2008 Apr 15;197(8):1133-44.PMID: 18476292 [PubMed - indexed for MEDLINE]Related articles

    49.

    Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.

    Data Collection on Adverse Events of Anti-HIV Drugs Study Group, Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD.

    Clin Infect Dis. 2008 Apr 1;46(7):1101-10.PMID: 18461712 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Incidence of pancreatitis in HIV-infected patients, and the association with antiretroviral therapy.

    Smith CJ, Mocroft A, Lundgren JD; EuroSIDA Study Group.

    AIDS. 2008 May 11;22(8):997-8. No abstract available. PMID: 18453864 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...